Literature DB >> 14703611

Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea.

Sun-Young Ahn1, Gwang-Cheon Jang, Jeon-Soo Shin, Kyung Mi Shin, Dong-Soo Kim.   

Abstract

Tumor necrosis factor (TNF)-alpha plays a major role in the pathogenesis of Kawasaki disease (KD), a systemic vasculitis primarily affecting young children. We performed this study to examine the serum levels of TNF-alpha and to investigate a possible relation to promoter polymorphism at positions -238 and -308 in KD patients in Korea. We obtained 48 paired serum samples from 24 patients in the acute and subacute stages of KD, and control sera from 12 age-matched children who were having routine blood samples taken before elective surgical procedures. Our studies showed a significant increase in serum levels of TNF-alpha measured in the acute stage of KD (24.1 +/- 9.4 pg/mL) compared to those in the subacute stage (11.8 +/- 5.8 pg/mL; p < 0.01) and normal controls (10.4 +/- 4.9 pg/mL; p < 0.01). Previous studies report that the presence of the A allele at positions -308 and -238 may be associated with higher TNF-alpha levels. However, our results showed that the frequency of the A allele at position -308 in the KD patients was the same as the controls (2 out of 24, 8.3% vs. 8.3%, odds ratio (OR)= 1.00), while the frequency of the A allele at position -238 in the KD patients was lower than the controls (0/24, 0% vs. 8.3%, OR=0.00); this difference though was not statistically significant. We concluded that although TNF-alpha levels were significantly elevated in the acute stage of KD, there was no significant difference in the frequency of the A allele at positions -238 and -308 between the KD and control groups in Korean patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14703611     DOI: 10.3349/ymj.2003.44.6.1021

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  7 in total

1.  Expression of nuclear factor -κBp65 in mononuclear cells in Kawasaki disease and its relation to coronary artery lesions.

Authors:  Wei Yin; Xiang Wang; Yan Ding; Hua Peng; Ya-Li Liu; Rui-Geng Wang; Ya-Ling Yang; Jun-Hui Xiong; Shi-Xiu Kang
Journal:  Indian J Pediatr       Date:  2011-06-18       Impact factor: 1.967

2.  The functions of endothelial progenitor cells were significantly improved after treatment with intravenous immunoglobulin and aspirin in children with Kawasaki disease.

Authors:  Ming Guo Xu; Li Na Men; Ying Zu; Chun Yu Zhao; Xiang Chun Meng; Tao Wang
Journal:  Pediatr Cardiol       Date:  2011-02-16       Impact factor: 1.655

Review 3.  Kawasaki disease.

Authors:  Dong Soo Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

4.  The CCR5 (-2135C/T) polymorphism may be associated with the development of Kawasaki disease in Korean children.

Authors:  Won Kyoung Jhang; Mi-Jin Kang; Hyun-Seung Jin; Jinho Yu; Byoung-ju Kim; Bong Seong Kim; Jong-Keuk Lee; Eul-Ju Seo; Han-Wook Yoo; In Sook Park; Young Mi Hong; Soo-Jong Hong
Journal:  J Clin Immunol       Date:  2008-07-15       Impact factor: 8.317

5.  Tumor necrosis factor-α-308 polymorphism is not associated with Kawasaki disease: A meta-analysis of case-control studies.

Authors:  Ye Yuan; Jinhua Piao; Na Lu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

Review 6.  The role of infection in Kawasaki syndrome.

Authors:  Nicola Principi; Donato Rigante; Susanna Esposito
Journal:  J Infect       Date:  2013-04-18       Impact factor: 6.072

7.  The association between the miR-146a rs2910164 C>G polymorphism and Kawasaki disease in a southern Chinese population.

Authors:  Li Zhang; Jinxin Wang; Di Che; Yanfei Wang; Xing Rong; Lei Pi; Yufen Xu; Wei Li; Ping Huang; Maoping Chu; Xiaoqiong Gu
Journal:  Biosci Rep       Date:  2018-07-02       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.